Rapid Micro Biosystems, Inc. Stock News

Rapid Micro Biosystems Inc. (RPID) CEO Rob Spignesi on Q4 2021 Results - Earnings Call Transcript

Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million

Rapid Micro Biosystems Inc - Class A (RPID) shares closed this week 20.4% lower than it did at the end of last week. The stock is currently down 31.6% year-to-date, down 66.0% over the past 12 months, and down 66.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $9.11 and as low as $6.39 this week.Shares closed 73.1% below its 52-week high and 13.9% above its 52-week low.Trading volume this week was 26.7% higher than the 10-day average and 73.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rapid Micro Biosystems Inc - Class A (RPID) shares closed today at 1.6% above its 52 week low of $9.00, giving the company a market cap of $314M. The stock is currently down 14.1% year-to-date, down 57.3% over the past 12 months, and down 57.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 52.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 5.9% lower than its 5-day moving average, 11.0% lower than its 20-day moving average, and 43.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rapid Micro Biosystems Inc (NASDAQ:RPID)s share price shot up 8.4% on Wednesday . The stock traded as high as $13.48 and last traded at $13.36. 917 shares were traded during mid-day trading, a decline of 99% from the average session volume of 154,133 shares. The stock had previously closed at $12.32. Several brokerages recently weighed []

Rapid Micro Biosystems Inc (NASDAQ:RPID) saw unusually-high trading volume on Wednesday . Approximately 3,197 shares changed hands during trading, a decline of 98% from the previous sessions volume of 156,330 shares.The stock last traded at $14.50 and had previously closed at $14.73. RPID has been the subject of several recent analyst reports. Cowen initiated coverage []

Rapid Micro Biosystems Inc (NASDAQ:RPID) shares hit a new 52-week low on Monday . The company traded as low as $15.37 and last traded at $15.44, with a volume of 1686 shares trading hands. The stock had previously closed at $15.99. A number of equities research analysts have weighed in on the stock. Morgan Stanley []

Rapid Micro Biosystems (NASDAQ:RPID) and Harvard Bioscience (NASDAQ:HBIO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Earnings & Valuation This table compares Rapid Micro Biosystems and Harvard Biosciences top-line revenue, []

Rapid Micro Biosystems (NASDAQ:RPID) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation. Profitability This table compares Rapid Micro Biosystems and Precipios net margins, return on equity and []

Rapid Micro Biosystems (NASDAQ:RPID) had its target price cut by Morgan Stanley from $26.00 to $24.00 in a report published on Monday, Price Targets.com reports. They currently have an equal weight rating on the stock. RPID has been the topic of a number of other reports. Cowen began coverage on shares of Rapid Micro Biosystems []

Related Stocks: RPID , ADGI , NUVL , TNGX , ARYE , KYMR , BCTG ,

Related Stocks: NTRA , MGNX , SLGC , RPID , SGHT , AMRS , LPTX , ISEE , CERE , EPIX , AVIR , APLS , SBTX , FRLN ,

Rapid Micro Biosystems Inc (NASDAQ:RPID) shares traded down 6.5% during trading on Friday following a dissappointing earnings announcement. The stock traded as low as $19.13 and last traded at $20.03. 102 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 160,380 shares. The stock had previously closed at []

LOWELL, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission